- Home
- Publications
- Publication Search
- Publication Details
Title
Targeting pattern recognition receptors in cancer immunotherapy
Authors
Keywords
-
Journal
Targeted Oncology
Volume 7, Issue 1, Pages 29-54
Publisher
Springer Nature
Online
2012-03-07
DOI
10.1007/s11523-012-0213-1
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Immunization with recombinant MAGE-A3 protein combined with adjuvant systems AS15 or AS02B in patients with unresectable and progressive metastatic cutaneous melanoma: A randomized open-label phase II study of the EORTC Melanoma Group (16032- 18031)
- (2017) W. H. Kruit et al. JOURNAL OF CLINICAL ONCOLOGY
- Recurrent Overexpression of c-IAP2 in EBV-Associated Nasopharyngeal Carcinomas: Critical Role in Resistance to Toll-like Receptor 3-Mediated Apoptosis
- (2015) Luc Friboulet et al. NEOPLASIA
- Toll-like Receptor 3 Regulates Angiogenesis and Apoptosis in Prostate Cancer Cell Lines through Hypoxia-Inducible Factor 1α
- (2015) Alessio Paone et al. NEOPLASIA
- Immunization of Malignant Melanoma Patients with Full-Length NY-ESO-1 Protein Using TLR7 Agonist Imiquimod as Vaccine Adjuvant
- (2014) S. Adams et al. JOURNAL OF IMMUNOLOGY
- Identification of RNA Sequence Motifs Stimulating Sequence-Specific TLR8-Dependent Immune Responses
- (2014) A. Forsbach et al. JOURNAL OF IMMUNOLOGY
- Priming CD8+ T cells with dendritic cells matured using TLR4 and TLR7/8 ligands together enhances generation of CD8+ T cells retaining CD28
- (2011) J. S. Pufnock et al. BLOOD
- Cancer Immunotherapy
- (2011) Robert O. Dillman CANCER BIOTHERAPY AND RADIOPHARMACEUTICALS
- Quantitative and Functional Alterations of Plasmacytoid Dendritic Cells Contribute to Immune Tolerance in Ovarian Cancer
- (2011) S. I. Labidi-Galy et al. CANCER RESEARCH
- Systemic Cancer Therapy with a Small Molecule Agonist of Toll-like Receptor 7 Can Be Improved by Circumventing TLR Tolerance
- (2011) C. Bourquin et al. CANCER RESEARCH
- Adjuvant Combination and Antigen Targeting as a Strategy to Induce Polyfunctional and High-Avidity T-Cell Responses against Poorly Immunogenic Tumors
- (2011) F. Aranda et al. CANCER RESEARCH
- Human Tumor Cells Killed by Anthracyclines Induce a Tumor-Specific Immune Response
- (2011) J. Fucikova et al. CANCER RESEARCH
- Immune Adjuvant Efficacy of CpG Oligonucleotide in Cancer Treatment Is Founded Specifically upon TLR9 Function in Plasmacytoid Dendritic Cells
- (2011) S. Nierkens et al. CANCER RESEARCH
- TLR3 as a Biomarker for the Therapeutic Efficacy of Double-stranded RNA in Breast Cancer
- (2011) B. Salaun et al. CANCER RESEARCH
- Activation of Toll-like Receptor 5 on Breast Cancer Cells by Flagellin Suppresses Cell Proliferation and Tumor Growth
- (2011) Z. Cai et al. CANCER RESEARCH
- Synthesis and immunological activities of novel Toll-like receptor 7 and 8 agonists
- (2011) Ekambar R. Kandimalla et al. CELLULAR IMMUNOLOGY
- Activation of Endothelial Toll-Like Receptor 3 Impairs Endothelial Function
- (2011) Sebastian Zimmer et al. CIRCULATION RESEARCH
- Innate immune DNA sensing pathways: STING, AIMII and the regulation of interferon production and inflammatory responses
- (2011) Glen N Barber CURRENT OPINION IN IMMUNOLOGY
- Immunogenic cell death of human ovarian cancer cells induced by cytosolic poly(I:C) leads to myeloid cell maturation and activates NK cells
- (2011) Kirsten Kübler et al. EUROPEAN JOURNAL OF IMMUNOLOGY
- Toll-like receptor 9 agonists as cancer therapeutics
- (2011) Udo Holtick et al. EXPERT OPINION ON INVESTIGATIONAL DRUGS
- DDX1, DDX21, and DHX36 Helicases Form a Complex with the Adaptor Molecule TRIF to Sense dsRNA in Dendritic Cells
- (2011) Zhiqiang Zhang et al. IMMUNITY
- Bacterial LPS up-regulated TLR3 expression is critical for antiviral response in human monocytes: evidence for negative regulation by CYLD
- (2011) Z. K. Pan et al. INTERNATIONAL IMMUNOLOGY
- Updated survival analysis in patients with stage IIIB or IV non-small-cell lung cancer receiving BLP25 liposome vaccine (L-BLP25): phase IIB randomized, multicenter, open-label trial
- (2011) Charles Butts et al. JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY
- Reply to D. Herchenhorn et al
- (2011) Ezra E.W. Cohen JOURNAL OF CLINICAL ONCOLOGY
- Nucleic acid recognition by Toll-like receptors is coupled to stepwise processing by cathepsins and asparagine endopeptidase
- (2011) Sarah E. Ewald et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Impaired Wound Healing with Defective Expression of Chemokines and Recruitment of Myeloid Cells in TLR3-Deficient Mice
- (2011) Q. Lin et al. JOURNAL OF IMMUNOLOGY
- cIAPs Block Ripoptosome Formation, a RIP1/Caspase-8 Containing Intracellular Cell Death Complex Differentially Regulated by cFLIP Isoforms
- (2011) Maria Feoktistova et al. MOLECULAR CELL
- The Ripoptosome, a Signaling Platform that Assembles in Response to Genotoxic Stress and Loss of IAPs
- (2011) Tencho Tenev et al. MOLECULAR CELL
- Immune parameters affecting the efficacy of chemotherapeutic regimens
- (2011) Laurence Zitvogel et al. Nature Reviews Clinical Oncology
- Phase III Multicenter Clinical Trial of the Sialyl-TN (STn)-Keyhole Limpet Hemocyanin (KLH) Vaccine for Metastatic Breast Cancer
- (2011) D. Miles et al. ONCOLOGIST
- Type I Interferon Drives Dendritic Cell Apoptosis via Multiple BH3-Only Proteins following Activation by PolyIC In Vivo
- (2011) Silvia A. Fuertes Marraco et al. PLoS One
- RA-inducible gene-I induction augments STAT1 activation to inhibit leukemia cell proliferation
- (2011) Lin-Jia Jiang et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Toll-Like Receptors in Angiogenesis
- (2011) Karsten Grote et al. TheScientificWorldJOURNAL
- The Toll-Like Receptor Gene Family Is Integrated into Human DNA Damage and p53 Networks
- (2011) Daniel Menendez et al. PLoS Genetics
- Small Interfering RNAs Induce Target-Independent Inhibition of Tumor Growth and Vasculature Remodeling in a Mouse Model of Hepatocellular Carcinoma
- (2010) Mathieu Bergé et al. AMERICAN JOURNAL OF PATHOLOGY
- Poly(I:C) induces intense expression of c-IAP2 and cooperates with an IAP inhibitor in induction of apoptosis in cancer cells
- (2010) Luc Friboulet et al. BMC CANCER
- Study of TLR3, TLR4 and TLR9 in breast carcinomas and their association with metastasis
- (2010) Salomé González-Reyes et al. BMC CANCER
- Sequence Variants in the TLR4 and TLR6-1-10 Genes and Prostate Cancer Risk. Results Based on Pooled Analysis from Three Independent Studies
- (2010) S. Lindstrom et al. CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION
- Toll-like Receptor 3–Mediated Suppression of TRAMP Prostate Cancer Shows the Critical Role of Type I Interferons in Tumor Immune Surveillance
- (2010) Arnold I. Chin et al. CANCER RESEARCH
- Therapeutic Targeting of TLR9 Inhibits Cell Growth and Induces Apoptosis in Neuroblastoma
- (2010) C. Brignole et al. CANCER RESEARCH
- Opposing Effects of Toll-like Receptor (TLR3) Signaling in Tumors Can Be Therapeutically Uncoupled to Optimize the Anticancer Efficacy of TLR3 Ligands
- (2010) R. Conforti et al. CANCER RESEARCH
- Toll-like receptor 9 expression in breast and ovarian cancer is associated with poorly differentiated tumors
- (2010) Regina Berger et al. CANCER SCIENCE
- TLR3 induction by anticancer drugs potentiates poly I:C-induced tumor cell apoptosis
- (2010) Manabu Taura et al. CANCER SCIENCE
- Intravesical therapy for superficial bladder cancer: A systematic review of randomised trials and meta-analyses
- (2010) Mike D. Shelley et al. CANCER TREATMENT REVIEWS
- The TLR7 agonists imiquimod and gardiquimod improve DC-based immunotherapy for melanoma in mice
- (2010) Fang Ma et al. Cellular & Molecular Immunology
- Survival of Patients with Newly Diagnosed Glioblastoma Treated with Radiation and Temozolomide in Research Studies in the United States
- (2010) S. A. Grossman et al. CLINICAL CANCER RESEARCH
- Listeria monocytogenes is sensed by the NLRP3 and AIM2 inflammasome
- (2010) Sarah Kim et al. EUROPEAN JOURNAL OF IMMUNOLOGY
- Expression of Toll-like receptor 9 in bone marrow cells of myelodysplastic syndromes is down-regulated during transformation to overt leukemia
- (2010) Nobuo Kuninaka et al. EXPERIMENTAL AND MOLECULAR PATHOLOGY
- Toll-like receptors as therapeutic targets in gastrointestinal diseases
- (2010) Pedro Pimentel-Nunes et al. EXPERT OPINION ON THERAPEUTIC TARGETS
- Control of Intestinal Homeostasis, Colitis, and Colitis-Associated Colorectal Cancer by the Inflammatory Caspases
- (2010) Jeremy Dupaul-Chicoine et al. IMMUNITY
- Association between toll-like receptor expression and human papillomavirus type 16 persistence
- (2010) Ibrahim I. Daud et al. INTERNATIONAL JOURNAL OF CANCER
- Triggering of TLR7 and TLR8 expressed by human lung cancer cells induces cell survival and chemoresistance
- (2010) Julien Cherfils-Vicini et al. JOURNAL OF CLINICAL INVESTIGATION
- In Situ Vaccination With a TLR9 Agonist Induces Systemic Lymphoma Regression: A Phase I/II Study
- (2010) Joshua D. Brody et al. JOURNAL OF CLINICAL ONCOLOGY
- Human CD141+(BDCA-3)+dendritic cells (DCs) represent a unique myeloid DC subset that cross-presents necrotic cell antigens
- (2010) Sarah L. Jongbloed et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Characterization of human DNGR-1+BDCA3+leukocytes as putative equivalents of mouse CD8α+dendritic cells
- (2010) Lionel Franz Poulin et al. JOURNAL OF EXPERIMENTAL MEDICINE
- MyD88-mediated signaling prevents development of adenocarcinomas of the colon: role of interleukin 18
- (2010) Rosalba Salcedo et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Generation of Th1-Polarizing Dendritic Cells Using the TLR7/8 Agonist CL075
- (2010) S. Spranger et al. JOURNAL OF IMMUNOLOGY
- Treatment Failure of a TLR-7 Agonist Occurs Due to Self-Regulation of Acute Inflammation and Can Be Overcome by IL-10 Blockade
- (2010) H. Lu et al. JOURNAL OF IMMUNOLOGY
- Double-Stranded RNA Induces Shedding of the 34-kDa Soluble TNFR1 from Human Airway Epithelial Cells via TLR3-TRIF-RIP1-Dependent Signaling: Roles for Dual Oxidase 2- and Caspase-Dependent Pathways
- (2010) M. Yu et al. JOURNAL OF IMMUNOLOGY
- EBV Latent Membrane Protein 1 Is a Negative Regulator of TLR9
- (2010) I. Fathallah et al. JOURNAL OF IMMUNOLOGY
- TLR3 and Rig-Like Receptor on Myeloid Dendritic Cells and Rig-Like Receptor on Human NK Cells Are Both Mandatory for Production of IFN- in Response to Double-Stranded RNA
- (2010) I. Perrot et al. JOURNAL OF IMMUNOLOGY
- Cutting Edge: Polyinosinic:Polycytidylic Acid Boosts the Generation of Memory CD8 T Cells through Melanoma Differentiation-Associated Protein 5 Expressed in Stromal Cells
- (2010) Y. Wang et al. JOURNAL OF IMMUNOLOGY
- Antitumor Activity and Immune Response Induction of a Dual Agonist of Toll-Like Receptors 7 and 8
- (2010) D. Wang et al. MOLECULAR CANCER THERAPEUTICS
- The AIM2 inflammasome is essential for host defense against cytosolic bacteria and DNA viruses
- (2010) Vijay A K Rathinam et al. NATURE IMMUNOLOGY
- Enzastaurin plus temozolomide with radiation therapy in glioblastoma multiforme: A phase I study
- (2010) N. Butowski et al. NEURO-ONCOLOGY
- Aspartate-glutamate-alanine-histidine box motif (DEAH)/RNA helicase A helicases sense microbial DNA in human plasmacytoid dendritic cells
- (2010) T. Kim et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- LGP2 is a positive regulator of RIG-I- and MDA5-mediated antiviral responses
- (2010) T. Satoh et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Expression of toll-like receptor-9 is increased in poorly differentiated prostate tumors
- (2010) Marja-Riitta Väisänen et al. PROSTATE
- Bifurcation of Toll-Like Receptor 9 Signaling by Adaptor Protein 3
- (2010) M. Sasai et al. SCIENCE
- Impaired Toll-like receptor 7 and 9 signaling: from chronic viral infections to cancer
- (2010) Ivan Hirsch et al. TRENDS IN IMMUNOLOGY
- Profound CD8+ T cell immunity elicited by sequential daily immunization with exogenous antigen plus the TLR3 agonist poly(I:C)
- (2010) Darin A. Wick et al. VACCINE
- BCR-mediated uptake of antigen linked to TLR9 ligand stimulates B-cell proliferation and antigen-specific plasma cell formation
- (2009) J. Eckl-Dorna et al. BLOOD
- The role of PAMPs and DAMPs in the pathogenesis of acute and recurrent anterior uveitis
- (2009) D. Wakefield et al. BRITISH JOURNAL OF OPHTHALMOLOGY
- Emerging targeted therapies for bladder cancer: a disease waiting for a drug
- (2009) Simon J. Dovedi et al. CANCER AND METASTASIS REVIEWS
- Targeted Activation of Innate Immunity for Therapeutic Induction of Autophagy and Apoptosis in Melanoma Cells
- (2009) Damià Tormo et al. CANCER CELL
- A possible mechanism of intravesical BCG therapy for human bladder carcinoma: involvement of innate effector cells for the inhibition of tumor growth
- (2009) Tomoe Higuchi et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- Triggering of Toll-like Receptor 4 Expressed on Human Head and Neck Squamous Cell Carcinoma Promotes Tumor Development and Protects the Tumor from Immune Attack
- (2009) M. J. Szczepanski et al. CANCER RESEARCH
- Proapoptotic signalling through Toll-like receptor-3 involves TRIF-dependent activation of caspase-8 and is under the control of inhibitor of apoptosis proteins in melanoma cells
- (2009) A Weber et al. CELL DEATH AND DIFFERENTIATION
- Critical Role for Asparagine Endopeptidase in Endocytic Toll-like Receptor Signaling in Dendritic Cells
- (2009) Fernando E. Sepulveda et al. IMMUNITY
- Toll-like receptors - sentries in the B-cell response
- (2009) Isabelle Bekeredjian-Ding et al. IMMUNOLOGY
- Double stranded-RNA-mediated activation of P21 gene induced apoptosis and cell cycle arrest in renal cell carcinoma
- (2009) Jared M. Whitson et al. INTERNATIONAL JOURNAL OF CANCER
- Effectiveness of imiquimod limited to dermal melanoma metastases, with simultaneous resistance of subcutaneous metastasis
- (2009) Kristin Turza et al. JOURNAL OF CUTANEOUS PATHOLOGY
- Distinct and complementary functions of MDA5 and TLR3 in poly(I:C)-mediated activation of mouse NK cells
- (2009) Stephen McCartney et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Dendritic cells require a systemic type I interferon response to mature and induce CD4+Th1 immunity with poly IC as adjuvant
- (2009) M. Paula Longhi et al. JOURNAL OF EXPERIMENTAL MEDICINE
- TLR3-Stimulated Dendritic Cells Up-regulate B7-H1 Expression and Influence the Magnitude of CD8 T Cell Responses to Tumor Vaccination
- (2009) V. Pulko et al. JOURNAL OF IMMUNOLOGY
- AS04, an Aluminum Salt- and TLR4 Agonist-Based Adjuvant System, Induces a Transient Localized Innate Immune Response Leading to Enhanced Adaptive Immunity
- (2009) A. M. Didierlaurent et al. JOURNAL OF IMMUNOLOGY
- TLR3 Ligand Induces NF- B Activation and Various Fates of Multiple Myeloma Cells Depending on IFN- Production
- (2009) D. Chiron et al. JOURNAL OF IMMUNOLOGY
- Role of atopic status in Toll-like receptor (TLR)7- and TLR9-mediated activation of human eosinophils
- (2009) A. Mansson et al. JOURNAL OF LEUKOCYTE BIOLOGY
- DAMPs and inflammatory processes: the role of redox in the different outcomes
- (2009) Sonia Carta et al. JOURNAL OF LEUKOCYTE BIOLOGY
- Impaired Plasmacytoid Dendritic Cell (PDC)-NK Cell Activity in Viremic Human Immunodeficiency Virus Infection Attributable to Impairments in both PDC and NK Cell Function
- (2009) S. J. Conry et al. JOURNAL OF VIROLOGY
- AIM2 activates the inflammasome and cell death in response to cytoplasmic DNA
- (2009) Teresa Fernandes-Alnemri et al. NATURE
- STING regulates intracellular DNA-mediated, type I interferon-dependent innate immunity
- (2009) Hiroki Ishikawa et al. NATURE
- Death receptor signal transducers: nodes of coordination in immune signaling networks
- (2009) Nicholas S Wilson et al. NATURE IMMUNOLOGY
- Activation of the NLRP3 inflammasome in dendritic cells induces IL-1β–dependent adaptive immunity against tumors
- (2009) François Ghiringhelli et al. NATURE MEDICINE
- HIN-200 Proteins Regulate Caspase Activation in Response to Foreign Cytoplasmic DNA
- (2009) T. L. Roberts et al. SCIENCE
- Molecular mechanisms involved in inflammasome activation
- (2009) Clare Bryant et al. TRENDS IN CELL BIOLOGY
- Toll-like receptor 3 is necessary for dsRNA adjuvant effects
- (2009) Bruno Salaun et al. VACCINE
- Ampligen: A potential toll-like 3 receptor adjuvant for immunotherapy of cancer
- (2009) B. Jasani et al. VACCINE
- Toll-like receptors: lessons to learn from normal and malignant human B cells
- (2008) D. Chiron et al. BLOOD
- Poly I:C enhances cycloheximide-induced apoptosis of tumor cells through TLR3 pathway
- (2008) Qun Jiang et al. BMC CANCER
- Comparison of human B cell activation by TLR7 and TLR9 agonists
- (2008) John A Hanten et al. BMC IMMUNOLOGY
- Toll-like receptors expressed in tumor cells: targets for therapy
- (2008) Li Yu et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- Toll-like receptor 3 triggers apoptosis of human prostate cancer cells through a PKC- -dependent mechanism
- (2008) A. Paone et al. CARCINOGENESIS
- An Exploratory Study of Systemic Administration of the Toll-like Receptor-7 Agonist 852A in Patients with Refractory Metastatic Melanoma
- (2008) R. Dummer et al. CLINICAL CANCER RESEARCH
- Antimicrobial peptides and self-DNA in autoimmune skin inflammation
- (2008) Michel Gilliet et al. CURRENT OPINION IN IMMUNOLOGY
- Length-dependent recognition of double-stranded ribonucleic acids by retinoic acid–inducible gene-I and melanoma differentiation–associated gene 5
- (2008) Hiroki Kato et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Immune Responses Detected in Urothelial Carcinoma Patients After Vaccination With NY-ESO-1 Protein Plus BCG and GM-CSF
- (2008) Padmanee Sharma et al. JOURNAL OF IMMUNOTHERAPY
- TLR7 Agonist 852A Inhibition of Tumor Cell Proliferation Is Dependent on Plasmacytoid Dendritic Cells and Type I IFN
- (2008) Jon R. Inglefield et al. JOURNAL OF INTERFERON AND CYTOKINE RESEARCH
- UNC93B1 delivers nucleotide-sensing toll-like receptors to endolysosomes
- (2008) You-Me Kim et al. NATURE
- The ectodomain of Toll-like receptor 9 is cleaved to generate a functional receptor
- (2008) Sarah E. Ewald et al. NATURE
- Sequence- and target-independent angiogenesis suppression by siRNA via TLR3
- (2008) Mark E. Kleinman et al. NATURE
- Silica crystals and aluminum salts activate the NALP3 inflammasome through phagosomal destabilization
- (2008) Veit Hornung et al. NATURE IMMUNOLOGY
- TRAM couples endocytosis of Toll-like receptor 4 to the induction of interferon-β
- (2008) Jonathan C Kagan et al. NATURE IMMUNOLOGY
- Proteolytic cleavage in an endolysosomal compartment is required for activation of Toll-like receptor 9
- (2008) Boyoun Park et al. NATURE IMMUNOLOGY
- 5′-triphosphate-siRNA: turning gene silencing and Rig-I activation against melanoma
- (2008) Hendrik Poeck et al. NATURE MEDICINE
- Toll-like receptor 9 (TLR9) agonists in the treatment of cancer
- (2008) A M Krieg ONCOGENE
- TLR signaling by tumor and immune cells: a double-edged sword
- (2008) B Huang et al. ONCOGENE
- Polymorphisms in Toll-like receptor genes and risk of cancer
- (2008) E M El-Omar et al. ONCOGENE
- RIG-I plays a critical role in negatively regulating granulocytic proliferation
- (2008) N.-N. Zhang et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Anti-tumor effect of DNA-based vaccination and dSLIM immunomodulatory molecules in mice with Ph+ acute lymphoblastic leukaemia
- (2008) Joachim Köchling et al. VACCINE
- Novel insights into the relationships between dendritic cell subsets in human and mouse revealed by genome-wide expression profiling
- (2008) Scott H Robbins et al. GENOME BIOLOGY
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now